Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2014
10/16/2014US20140309240 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309237 Compounds that modulate intracellular calcium
10/16/2014US20140309215 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors
10/16/2014US20140309210 Indazole compounds, compositions and methods of use thereof
10/16/2014US20140309209 Pyrazine Kinase Inhibitors
10/16/2014US20140309206 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/16/2014US20140308282 Pharmaceutical compounds
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
10/14/2014US8859784 Stereomerically pure fused bicyclic proline compounds useful for preparing hepatitis C protease inhibitors
10/14/2014US8859783 Indirubin-3′-oxime derivatives as potent cyclin dependent kinase inhibitors
10/14/2014US8859781 No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents
10/14/2014US8859780 Benzimidazole derivatives as selective blockers of persistent sodium current
10/14/2014US8859600 Acetone solvate crystals of trityl olmesartan medoxomil
10/14/2014US8859596 Compounds as cannabinoid receptor ligands
10/14/2014US8859595 Potent and selective inhibitors of hepatitis C virus
10/14/2014US8859591 Glucagon receptor modulators
10/14/2014US8859588 Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
10/14/2014US8859580 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
10/14/2014US8859574 Compounds and compositions as kinase inhibitors
10/14/2014US8859573 Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2
10/14/2014US8859570 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
10/14/2014US8859559 Substituted pyrazines and their use in the treatment of disease
10/14/2014US8859552 Methods of utilizing arylpiperazine derivatives
10/14/2014US8859549 Potassium channel modulators
10/14/2014US8859548 Compounds and compositions as protein kinase inhibitors
10/14/2014US8859547 Pyridazinone derivatives
10/14/2014US8859529 Compounds for the treatment of inflammatory disorders
10/14/2014US8859113 Carbazole derivatives and organic light-emitting diode device using the same
10/14/2014US8859111 Materials for organic electroluminescent devices
10/09/2014WO2014165815A2 Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
10/09/2014WO2014165127A1 Pyrrole amide inhibitors
10/09/2014WO2014165075A1 Antibacterial agents
10/09/2014WO2014164756A1 Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
10/09/2014WO2014164558A1 Pyridinyl and fused pyridinyl triazolone derivatives
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014162319A2 Oxindole compounds, solvent-free synthesis and use thereof
10/09/2014WO2014162126A1 Urea derivatives useful as kinase inhibitors
10/09/2014WO2014162121A1 Kinase inhibitors based upon n-alkyl pyrazoles
10/09/2014WO2014161808A1 Novel n-(2,3-dihydro-1h-pyrrolo[2,3-b]jpyridin-5-yl)-4- quinazolinamine and n-(2,3-dihydro-1h-indol-5-yl)-4- quinazolinamine derivatives as perk inhibitors
10/09/2014US20140303372 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
10/09/2014US20140303207 Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
10/09/2014US20140303186 Nitrogen-containing fused ring compounds as crth2 antagonists
10/09/2014US20140303170 Compounds for treating disease, for administering, and for pharmaceutical compositions
10/09/2014US20140303168 Phthalazines as potassium ion channel inhibitors
10/09/2014US20140303167 Cdk9 inhibitors in the treatment of midline carcinoma
10/09/2014US20140303164 Therapeutic compounds
10/09/2014US20140303163 Use of kinase inhibitors in preventing and treating inflammatory disorder
10/09/2014US20140303156 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303139 Pyrimidines as sodium channel blockers
10/09/2014US20140302010 Substituted benzimidazoles
10/08/2014EP2787549A1 Organic light emitting device and delayed fluorescent material and compound used therein
10/08/2014EP2785712A1 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof
10/08/2014EP2785711A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785710A1 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
10/08/2014EP2785709A1 Aminopyrimidine derivatives as lrrk2 modulators
10/08/2014EP2785708A1 Insecticidal triazinone derivatives
10/08/2014EP2785707A1 Novel 2h-indazoles as ep2 receptor antagonists
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785696A1 Novel compounds
10/08/2014EP2785692A1 Substituted anilines as ccr(4) antagonists
10/08/2014EP2785445A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction
10/07/2014US8853420 Compounds
10/07/2014US8853418 Cyclopentylpyrazoles as N-type calcium channel blockers
10/07/2014US8853416 Chemical compounds
10/07/2014US8853398 Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853390 Processes for preparing 1,2-substituted cyclopropyl derivatives
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853243 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
10/07/2014US8853230 Inhibitors of JAK
10/07/2014US8853214 Pyridazine compounds for controlling invertebrate pests
10/07/2014US8853211 Pyridazinone derivatives
10/07/2014US8853209 1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives
10/07/2014US8853202 Modulators of CXCR7
10/07/2014US8853199 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10/07/2014US8853139 Detergent-dispersant, additive composition for lubricant, and lubricant composition
10/07/2014US8852599 Immunoconjugates, compositions for making them, and methods of making and use
10/07/2014US8852553 N-alkoxyamide conjugates as imaging agents
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014160471A2 Articles and methods comprising persistent carbenes and related compositions
10/02/2014WO2014160430A1 Small molecule lrrk2 and erk5 inhibitors
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014160181A1 Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders
10/02/2014WO2014159993A1 Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis
10/02/2014WO2014159690A1 Dna-pk inhibitors
10/02/2014WO2014159511A1 Deuterated pacritinib
10/02/2014WO2014159012A1 Azetidinyloxyphenylpyrrolidine compounds
10/02/2014WO2014158998A1 Substituted pyridine and pyrazine compounds as pde4 inhibitors
10/02/2014WO2014157687A1 1,2,4-triazine-6-carboxamide derivative with acetamide group
10/02/2014WO2014157584A1 Method for producing [18f]f- or fluorescent dye-labeled pegylated bioactive substance, and analysis of in vivo kinetics thereof
10/02/2014WO2014157574A1 Condensed fluoranthene compound, material for organic electroluminescent element using this compound, organic electroluminescent element using this material, and electronic device
10/02/2014WO2014157494A1 Material for organic electroluminescent elements, organic electroluminescent element, display device and lighting device
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014154925A1 Neurogenic compounds comprising melatonin and the efficacy thereof in in vivo experiments for use in the treatment of diseases of the nervous system
10/02/2014WO2014154828A1 Pyridazinone derivatives as herbicides
10/02/2014WO2014154723A1 Novel pyrrole derivatives for the treatment of cancer
10/02/2014WO2014154682A1 Novel viral replication inhibitors
10/02/2014WO2014154612A1 Novel pyridine derivatives
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 626